Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Ampio Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Ampio Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Buchi J Kevin | Director | 146,858 | Jun 13, 2023 | 0 |
| Martino Michael A | CEO | 76,890 | May 26, 2023 | 0 |
| Stevens David R | Director | 103,971 | May 12, 2023 | 0 |
| Jobes Elizabeth Varki | Director | – | Mar 2, 2022 | 0 |
| Bar-Or David | Director | – | Feb 10, 2022 | 0 |
| Macaluso Michael | Director | 2,624,882 | Jan 4, 2022 | 0 |
| Stokely Dan | CFO | 312,274 | Jan 4, 2022 | 0 |
| Cherevka Holli | PRESIDENT AND COO | 410,820 | Jan 4, 2022 | 0 |
| Coelho Philip H | Director | – | Jan 3, 2022 | 0 |
| Giles Richard B | Director | – | Jan 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 (view filing)12:07 PM ET | Jun 9 | 4 days | Buchi J KevinDirector | PPurchase | +21.9K | $0.2875 | +$6.28K | +17.5%146.9K after | |
| Jun 9, 2023 (view filing)2:26 PM ET | Jun 8 | 1 day | Buchi J KevinDirector | PPurchase | +25.0K | $0.296 | +$7.40K | +25.0%125.0K after | |
| May 26, 2023 (view filing)1:30 PM ET | May 24 | 2 days | Martino Michael ACEO | PPurchase | +76.9K | $0.2877 | +$22.1K | New position76.9K after | |
| May 17, 2023 (view filing)4:25 PM ET | May 16 | 1 day | Buchi J KevinDirector | PPurchase | +32.5K | $0.2743 | +$8.92K | +48.2%100.0K after | |
| May 16, 2023 (view filing)3:30 PM ET | May 12-15 | 4 days | Buchi J KevinDirector | PPurchase | +67.5K | $0.2426 | +$16.4K | New position67.5K after | 2 lots |
| May 12, 2023 (view filing)5:26 PM ET | May 11-12 | 1 day | Stevens David RDirector | PPurchase | +95.0K | $0.2187 | +$20.8K | +1,059.0%104.0K after | 3 lots |